T·Time Launches Cash-Pay Compounded GLP-1 and GIP
Austin, TX, Oct.
09, 2026 (GLOBE NEWSWIRE) -- T·Time Health Inc., the telehealth brand at ttime.men, has launched cash-pay compounded injectable semaglutide and tirzepatide with one published rate regardless of prescribed dose.
Source: Financialcontent — https://www.financialcontent.com/article/gnwcq-2026-10-9-ttime-launches-cash-pay-compounded-glp-1-and-gip-injections-with-flat-pricing